{"name": "Bicycle Therapeutics",
 "permalink": "bicycle-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/bicycle-therapeutics",
 "homepage_url": "http://www.bicycletherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "rolf.guenther@bicycletherapeutics.com",
 "phone_number": "+44 (0)1223 497 399",
 "description": "",
 "created_at": "Tue Apr 03 02:49:23 UTC 2012",
 "updated_at": "Tue Dec 11 13:39:40 UTC 2012",
 "overview": "\u003Cp\u003EBicycle Therapeutics is a biotechnology company based at the Babraham Research Campus in Cambridge, U.K. developing a novel technology for the creation of a new generation of biotherapeutics which combine the desirable features of small molecules and biopharmaceuticals. Bicycle technology is based on discoveries made at the MRC Laboratory of Molecular Biology in Cambridge by co-founders, Professor Christian Heinis and Sir Gregory Winter, which have been developed at the company into a robust technology platform under the leadership of Dr. John Tite (CSO). The company is funded by Atlas Venture, Novartis Venture Fund, SV Life Sciences and SR One.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       57],
      "assets/images/resized/0018/2326/182326v1-max-150x150.png"],
     [[250,
       96],
      "assets/images/resized/0018/2326/182326v1-max-250x250.png"],
     [[260,
       100],
      "assets/images/resized/0018/2326/182326v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Rolf",
      "last_name": "H. Guenther",
      "permalink": "rolf-h-guenther",
      "image": null}},
   {"is_past": false,
    "title": "CSO",
    "person":
     {"first_name": "John",
      "last_name": "Tite",
      "permalink": "john-tite",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u00a33.75M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2012/12/bicycle-therapeutics-raises-3-75m-funding.html",
    "source_description": "Bicycle Therapeutics Raises \u00a33.75M in Funding",
    "raised_amount": 3750000.0,
    "raised_currency_code": "GBP",
    "funded_year": 2012,
    "funded_month": 12,
    "funded_day": 10,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Atlas Venture",
         "permalink": "atlas-venture",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0000/3403/3403v2-max-150x150.png"],
             [[250,
               53],
              "assets/images/resized/0000/3403/3403v2-max-250x250.png"],
             [[297,
               63],
              "assets/images/resized/0000/3403/3403v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SR One",
         "permalink": "sr-one",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Astellas Venture Management",
         "permalink": "astellas-venture-management",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0004/6637/46637v3-max-150x150.png"],
             [[160,
               64],
              "assets/images/resized/0004/6637/46637v3-max-250x250.png"],
             [[160,
               64],
              "assets/images/resized/0004/6637/46637v3-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Meditrina Building",
    "address2": "Babraham Research Campus",
    "zip_code": "CB22 3AT",
    "city": "Cambridge ",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}